Paper Details

  1. Home
  2. Paper Details

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Author: ChaudhryV, KatzbergH, PatwaH S, Rae-GrantA D, SoY T

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

IV immunoglobulin (IVIg) is an effective treatment for Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and possibly for myasthenia gravis, multifocal motor neuropathy, and Lambert-Eaton myasthenic syndrome.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the evidence for the efficacy of IV immunoglobulin (IVIg) to treat neuromuscular disorders. METHODS: The MEDLINE, Web of Science, and EMBASE databases were searched (1966-2009). Selected articles were rated according to the American Academy of Neurology's therapeutic classifica...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1212/WNL.0b013e31824de293

データ提供：米国国立医学図書館（NLM）

Intravenous Immunoglobulin (IVIg): A Valuable Tool for Treating Neuromuscular Disorders

The field of neurology is constantly striving to find effective treatments for debilitating neuromuscular disorders. This study provides a comprehensive review of the evidence supporting the use of intravenous immunoglobulin (IVIg) for treating a variety of neuromuscular conditions. The research offers valuable insights into the therapeutic potential of IVIg in managing these challenging diseases.

IVIg Demonstrates Efficacy in Treating Multiple Neuromuscular Disorders

The study confirms the efficacy of IVIg in treating several neuromuscular disorders, including Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis. This highlights the importance of IVIg as a valuable therapeutic option for patients suffering from these conditions.

Understanding the Role of IVIg in Neuromuscular Disorders

This research provides a comprehensive overview of the current evidence supporting the use of IVIg in treating a wide range of neuromuscular disorders. It emphasizes the importance of personalized treatment approaches, considering individual patient needs and characteristics.

Dr.Camel's Conclusion

This study provides a valuable roadmap for understanding the therapeutic potential of IVIg in treating neuromuscular disorders. It's like finding a well-worn path through the vast desert of medical knowledge. As a researcher, I am encouraged by the progress being made in developing effective treatments for these complex conditions. The research emphasizes the importance of continued exploration and innovation in the field of neurology.

Date :
  1. Date Completed 2012-05-15
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

22454268

DOI: Digital Object Identifier

10.1212/WNL.0b013e31824de293

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.